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Abstract
In order to model squamous cell carcinoma development in vivo, researchers have long preferred hairless mouse models
such as SKH-1 mice that have traditionally been classified as ‘wild-type’ mice irrespective of the genetic factors underlying
their hairless phenotype. The work presented here shows that mutations in the Hairless (Hr) gene not only result in the
hairless phenotype of the SKH-1 and Hr
2/2 mouse lines but also cause aberrant activation of NFkB and its downstream
effectors. We show that in the epidermis, Hr is an early UVB response gene that regulates NFkB activation and thereby
controls cellular responses to irradiation. Therefore, when Hr expression is decreased in Hr mutant animals there is a
corresponding increase in NFkB activity that is augmented by UVB irradiation. This constitutive activation of NFkB in the Hr
mutant epidermis leads to the stimulation a large variety of downstream effectors including the cell cycle regulators cyclin
D1 and cyclin E, the anti-apoptosis protein Bcl-2, and the pro-inflammatory protein Cox-2. Therefore, Hr loss results in a state
of uncontrolled epidermal proliferation that promotes tumor development, and Hr mutant mice should no longer be
considered merely hairless ’wild-type’ mice. Instead, Hr is a crucial UVB response gene and its loss creates a permissive
environment that potentiates increased tumorigenesis.
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Introduction
As a group, non-melanoma skin cancers (NMSC) are the most
common type of cancer in the US with a combined incidence of
over 2 million new cases annually [1]. Squamous cell carcinoma
(SCC) is the second most common form of NMSC and is the most
likely type to lethally metastasize, which makes understanding
SCC development crucially important to human health [2]. In
recent years, several genetic pathways have been implicated in the
development of SCCs, particularly the ras and NFkB pathways
([3,4], reviewed in [5]), but despite these advances, the molecular
events leading to SCC development and progression remain
poorly understood. Current research strategies utilize mice strains
that lack hair to model carcinogenesis using either UV irradiation
or chemical carcinogenesis since researchers prefer not to perform
repeated shaving or depilation to visualize tumor development.
Particularly favored strains feature mutations in the Hairless (Hr)
gene (Entrez Gene ID 15460) that result in almost complete hair
loss early in life [6].
Hairless mutant mice first appeared in the literature in the 1930’s
when they were described as having a striking wave of hair loss
that occurs in a rostral to caudal manner starting at 3 weeks of age
[6,7,8,9]. Some fifty years later, Hr mutant mice were widely
adopted as a convenient model for skin carcinogenesis studies and
were discovered to be uniquely susceptible to both UV induced
and chemical carcinogenesis [10,11,12]. Since then, the molecular
basis of the Hairless phenotype has been established as either a
proviral insertion into exon 6, as in the case of Hr
hr and SKH-1
animals [13,14], or point mutations, as is the case of the Hr
rh
animals [15,16,17]. Despite the knowledge that these strains have
a mutated Hr gene, many carcinogenesis studies continue to use
them and refer to unirradiated/untreated animals as ’wild-type
hairless’ mice.
Two early experiments using different Hairless mutant animals
suggested that the increased susceptibility to carcinogenesis was, in
fact, due to disruption of Hr. First, Iversen and Iversen (1976)
showed increased tumorgenesis in Hairless mice bearing the Hr/Hr
Oslo mutation as compared to wild-type, hairy littermates when
both cohorts were exposed to a chemical carcinogenesis protocol.
Secondly, Stoye et al. (1988) described the appearance and
propagation of a revertant, hairy mouse (Hr
hr+) that spontaneously
lost the proviral insertion in the Hr allele. When used in both
chemical and UV induced carcinogenesis protocols, the Hr
hr+ mice
were found to have develop less tumors as compared to their Hr
hr
counterparts [11,18]. Taken together, these genetic data suggested
that Hairless is a key determinant of skin tumorigenesis.
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39691Due to the overall phenotype of Hairless mutant mice, it has long
been hypothesized that Hairless plays crucial roles in both the
interfollicular epidermis and hair follicle. Supporting this hypoth-
esis is the fact that Hr has been shown to be abundantly expressed
in the suprabasal layers of the interfollicular epidermis, the matrix
region of the hair follicle in catagen, and other follicular
compartments such as the dermal papillae [19]. We (and others)
have established a role for Hairless in the regressing catagen hair
follicle [20,21,22], yet its function in the interfollicular epidermis
has remained elusive. What has been deduced so far is that
Hairless functions as a transcriptional co-factor that interacts with
several nuclear hormone receptors such as the Vitamin D receptor
(VDR) and thyroid hormone receptor (TR) (reviewed in [23]). In
addition to a VDR/TR binding domain, Hr also contains a zinc
finger domain, a nuclear localization signal and a putative Jumonji
C domain (reviewed in [23]). Altogether, the presence of these
multiple domains raises the possibility that Hr regulates multiple
pathways thereby having pleotropic effects in the epidermis and
influencing tumor susceptibility.
UV induced tumorigenesis occurs, in part, through the
activation of the NFkB pathway and subsequent cellular stress
and inflammation, therefore, one of the key UV response
mechanisms is regulation of the NFkB pathway (reviewed in
[24]). Furthermore, constitutive activation of the NFkB pathway is
a hallmark of several types of tumors including SCCs [25,26,27]
while its inhibition is a known chemoprevention for several tumor
types (reviewed in [28]). Recent work from our lab has shown that
in primary human keratinocytes HR is an early UVB response
gene that regulates UVB induced NFkB activation thereby
modulating cell cycling [29]. Due to these in vitro results and the
clear role of the NFkB pathway in UV induced carcinogenesis, we
postulated a connection between Hr and the NFkB pathway in
vivo. Here, we present multiple lines of evidence demonstrating
that disruption of the Hr gene leads to constitutive activation of the
NFkB pathway, uncovering the molecular mechanism of the skin
tumorigenesis susceptibility of Hairless mutant mice for the first
time.
Results
Hr is rapidly upregulated in response to UVB and loss of
Hr increases susceptibility to UVB induced tumorigenesis
In order to place our studies in the context of earlier work, we
first confirmed that the mouse lines SKH-1 and Hr
hr (hereafter
referred to as Hr
2/2) both contained the mutation, a proviral
insertion disrupting the open reading frame of Hr (Figure S1). We
then quantified and compared the level of Hr mRNA from whole
skin extracts of Hr
2/2, SKH-1, and WT littermates. Both Hr
2/2
and SKH-1 animals exhibited significantly lower levels of Hr
mRNA that equaled an ,70% decrease in expression (Figure 1).
Our previous work showed that Hr is expressed in suprabasal
kerationcytes [19,20] and is involved in the early UV response
mechanism in primary human kerationcytes [29]. Therefore, we
decided to focus our future experiments on the epidermis. In order
to implicate Hr in the UV response pathway in vivo, we used real
time PCR to evaluate Hr levels in the WT (Hr
+/+) epidermis at
baseline as compared to 1, 8, and 24 hrs after a single, acute UVB
dose. We observed a three-fold increase in epidermal Hr mRNA
transcript levels from baseline (3.02860.6147) as early as 8 hrs
post UVB exposure (Figure 1B). Thus, Hr is rapidly transcription-
ally activated in response to acute UVB suggesting that Hr plays a
role in the immediate UVB response.
To assess the impact of Hr mutations to UVB response, we
performed a long-term UVB tumorigenesis protocol [180 mJ/
cm
2, the equivalent of 2 MEDS [30,31], three times a week for a
total of 50 weeks] using Hr
2/2 mutants and strain-matched WT
(Hr
+/+) animals. Neither WT (Hr
+/+) nor Hr
2/2 animals showed
any signs of papilloma formation at 22 weeks, however by week
30, Hr
2/2 animals began to develop small papillomas (Figure S2).
50 weeks into the protocol, the Hr
2/2 animals had an average of
22 tumors that necessitated the termination of the study (Figure 2).
In contrast, WT (Hr
+/+) animals showed no sign of tumor or
papilloma formation at any time during the study.
Histological analysis of tissues obtained from the tumors in Hr
2/
2 animals at 50 weeks indicated that they were highly aggressive
SSCs, while there was no evidence of even microscopic tumor
formation in WT (Hr
+/+) skin (Figure 2B). Since the only known
genetic difference between Hr
2/2 animals and WT (Hr
+/+)
littermates was the Hairless mutation (Figure 1), these results
demonstrate that the disruption of Hairless was directly responsible
for conferring tumor susceptibility.
The Hairless mutant epidermis is hyperproliferative both
basally and in response to UVB
Given the evidence in the literature and the results of our long-
term UVB study, we next investigated the molecular role of Hr in
the UVB response pathways. For these studies we used a single,
acute UVB dose (180 mJ/cm
2) and assessed early time points (1, 8,
Figure 1. Hairless mutants have lower levels of Hr, an early a
UVB response gene.A )Hr expression was measured in whole skin
extracts by quantitative RT-PCR using primers designed to several
locations in the Hr coding sequence. The Hr
2/2 and SKH-1 Hairless
mutant strains have significantly decreased levels of Hr compared to
WT. B) Hr expression was also measured in WT (Hr
+/+) epidermis before
and after UVB (100 mJ/cm
2) exposure at 1, 8 and 24 hrs. Hr expression
significantly increased at the 8 hr time point.
doi:10.1371/journal.pone.0039691.g001
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effects of a long term UVB protocol.
Using epidermal morphometry, we found a significant increase
in epidermal thickness both before and after UVB in Hr
2/2 mice
as compared to wildtype conterparts (Figure 3A). At baseline, Hr
2/
2 mice have a significantly thicker epidermis indicating the
possibility of a hyperproliferative phenotype. Increased epidermal
thickness in Hr
2/2 skin is maintained after UVB exposure with
gradual increases at the indicated timepoints. We hypothesized
that such an increase in epidermal thickness was due to either
increased numbers of proliferating keratinocytes or a defect in
apoptosis.
Therefore, we investigated the amount of proliferation found in
the Hairless mutant epidermis by staining skin sections from Hr
2/2
and their respective WT littermates with the proliferation marker
Ki67. As seen in Figure 3B, the percent of Ki67 positive cells
found in the non-irradiated Hr
2/2 epidermis was significantly
higher than in the WT epidermis [0.196960.0246 (WT) vs
0.464960.0772 (Hr
2/2) as measured by the amount of Ki67
positive basal cells as a percentage of total basal cells). Throughout
Figure 2. Mutations in Hr render animals susceptible to UVB-
induced tumorigenesis. A) Female Hr
2/2 (n=10) and age/sex
matched WT littermates (Hr
+/+) were irradiated using 180 mJ/cm
2
UVB three times a week for a total of 50 weeks and the number of
tumors per animal were recorded on a weekly basis. WT littermates
never developed tumors or papillomas, while Hr
2/2 animals developed
tumors by 30 weeks. B) After 50 weeks of irradiation, Hr
2/2 mice had
obvious tumors and histological analysis revealed that the majority of
the tumors were aggressive SSCs. In contrast, WT animals did not
develop any tumors even at the microscopic level.
doi:10.1371/journal.pone.0039691.g002
Figure 3. Hairless mutant epidermis is highly proliferative and
exhibits a defective UVB response. A) Assessment of epidermal
thickness using epidermal morphometry on H&E stained sections
indicates that Hr
2/2 mice have significantly greater thickness prior to
UVB (180 mJ/cm
2) as compared to WT controls. Epidermal thickness
remains elevated after UVB exposure. B) Skin sections were stained with
Ki-67 to identify proliferating basal keratinocytes both at baseline and
after UVB exposure at the specified time points. Hr
2/2 mice had a
significantly higher percentage of Ki-67 positive cells at baseline as
compared to WT and continued to have an elevated amount of Ki-67
positive cells after UVB. C) Skin sections were stained with TUNEL to
identify apoptotic cells both at baseline and at the designated time
points. The number of TUNEL positive cells was plotted per 2.5 mm
section of skin. Hr
2/2 mice have a significantly lower number of TUNEL
positive cells at 1 hr and 24 hr post UVB compared to WT.
doi:10.1371/journal.pone.0039691.g003
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2/2 epidermis continued to exhibit
a higher amount of proliferation than WT epidermis. Altogether
this data indicated that the epidermal thickening seen in Figure 3A
may, in part, be due to increased proliferation in the Hairless
mutant epidermis.
In order to determine if the epidermal thickening could be
partially attributed to defects in apoptosis, TUNEL staining was
also performed (Figure 3C). We found that at homeostasis both
WT and Hr
2/2 epidermis contained a low level of apoptosis that
increased 1 hr after UVB exposure. However, the amount of
apoptosis found in the Hr
2/2 epidermis was approximately 3
times less than in WT controls. This trend continued at 8 and
24 hrs with the level of apoptosis in the Hr
2/2 epidermis always
being significantly less than that found in WT epidermis. When
taken together with the proliferation data, this suggests that
apoptosis may be impaired by loss of Hr; perhaps due to signals
favoring proliferation or possibly because of the increased
epidermal thickness partially shielding the keratinocytes from
UVB irradiation.
Loss of Hr leads to constitutively activated NFkB
NFkB has long been known to play a role in UVB induced
tumorigenesis and forms a nexus of proliferative and apoptotic
pathways; additionally, our previous work shows that HR
regulates NFkB in vitro [29]. We therefore theorized that Hr and
NFkB may be mechanistically related in a similar fashion in vivo.
To investigate a possible connection between the two proteins, we
examined p65 protein levels in Hr
2/2 and matching WT (Hr
+/+)
littermate epidermis with and without acute UVB irradiation using
Western blotting (Figure 4A). Prior to irradiation, Hr
2/2
epidermis had a significantly higher amount of the p65 subunit
of NFkB. Hr
2/2 epidermis continued to express higher levels of
p65 at 1 hr, 8 hrs, and 24 hrs post-UVB irradiation. Altogether
this indicates that the lack of Hr in the Hr
2/2 epidermis results in a
constitutively upregulated NFkB pathway.
In order to determine if the increase in p65 protein levels
correlated with activation of the NFkB signaling pathway
following acute UVB exposure, we examined Hr
2/2 and WT
(Hr
+/+) skin sections using an antibody against the phosphorylated
inhibitor of NFkB signaling, IkBa. Activation of the NFkB
complex is dependent on IkBa phosphorylation (p-IkBa) and
subsequent degradation that allows nuclear translocation of the
NFkB complex [32]. In addition to being upstream of NFkB, IkBa
is also a known target gene that is transcriptionally regulated by
NFkB [32]. Therefore, NFkB and IkBa form a positive feedback
loop and p-IkBa, when assessed in conjunction with the overall
increased levels of p65, can be used as an indicator to specifically
localize the activated NFkB pathway [33].
Staining of non-irradiated Hr
2/2 skin showed the presence of p-
IkBa throughout all the epidermal layers, including the basal
layer, while in WT (Hr
+/+) skin IkBa expression was restricted to
the differentiated, suprabasal layers (Figure 4B). This clear
demarcation of p-IkBa expression suggests that perturbation of
NFkB signaling in basal keratinocytes may be responsible for the
dysregulated proliferation and apoptosis observed in Hairless
mutants. In response to acute UVB, we observed a gradual
increase in the levels of p-IkBa in WT (Hr
+/+) skin, with signaling
in the basal keratinocytes beginning at 8 hrs post-UVB irradiation
(Figure 4B). This expression pattern coincides with the time point
previously observed to have a significantly higher amount of Hr
mRNA in the WT epidermis after acute irradiation (Figure 1B). As
expected, the intensity of p-IkBa signaling increased in response to
UVB exposure in both the WT (Hr
+/+) and Hr
2/2 mutant skin
and by 24 hrs post UVB irradiation, both genotypes showed
uniform p-IkBa staining in all layers of the epidermis with
comparable intensity.
To study the role of NFkB activation in the increased
susceptibility of Hairless mutant mice to tumorigenesis, we returned
to the non-tumor bearing skin samples generated in the long-term
irradiation study described in Figure 2. Interestingly, p-IkBa
staining appeared in the basal and suprabasal layer of the mutant
epidermis by week 25, a time point prior to tumor development
(Figure 4C). In contrast, at the same timepoint, the WT (Hr
+/+)
epidermis continued to show only suprabasal localization of p-
IkBa. By week 30 (when tumors were first observed on Hr
2/2
mice) the staining pattern remained the same in both sets of
animals, though the Hr
2/2 epidermis had a higher intensity of
staining. The intensity of the p-IkBa staining in the Hr
2/2
epidermis continued to increase at week 42 and plateaued at
week 50, while the WT (Hr
+/+) epidermis only began to show
staining in the basal layer of the epidermis at week 42 which
increased at week 50.
Pharmacological inhibition of NFkB signaling reduces
UVB induced tumorigenesis in Hairless mutant mice
We next reasoned that blockade of NFkB signaling in vivo should
inhibit tumor formation in Hairless mutant mice. Therefore, we
performed chronic UVB tumor induction studies while simulta-
neously treating the mice with a pharmacological inhibitor of
NFkB, pyrrolidinedithiocarbomate (PDTC), which was given ad
libitum the mice’s drinking water. PDTC suppresses NFkB DNA-
binding activity and IkBa degradation thereby inhibiting NFkB
activation [34]. 60 SKH-1 mice were divided into two groups:
group-I mice received tap water and group-II mice received
PDTC (0.5%) supplemented drinking water. All mice were
irradiated with UVB, 180 mJ/cm
2 twice a week for 35 weeks,
which was sufficient to induce tumorigenesis both with and
without PDTC treatment (Figure 5A and B).
PDTC and its concomitant reduction in NFkB activity
significantly reduced tumorigenesis by approximately 60%, as
measured in average tumor number, throughout the duration of
the irradiation protocol (Figure 5A). Average tumor volume was
also significantly decreased in the animals treated with PDTC
(Figure 5B). Inhibition of the NFkB pathway altered gross tumor
morphology suggesting that the tumors that formed on the PDTC
treated animals were more likely to be papillomas than SCCs. In
contrast, the animals given only tap water developed signs of
aggressive SCCs (Figure S3A). Taken together, these results
demonstrate that the tumor susceptibility of the SKH-1 animals
is dependent on the overactivation of the NFkB pathway that is a
downstream result of Hairless mutation.
We next performed a detailed molecular analysis of the NFkB
pathway in the PDTC treated SKH-1 animals (Figure 5C-F). For
this analysis we used the non-tumor bearing skin and the tumors
from the PDTC treated and control SKH-1 animals that had been
irradiated for 35 weeks. In addition to analyzing whole tumors in
this study, the epidermis was isolated from non-tumor bearing skin
in order to localize the biochemical effects of the PDTC treatment.
Our initial hypothesis was that non-tumor bearing skin of the
PDTC treated animals would exhibit reduced NFkB signaling
thereby indicating less tumor promotion when NFkB activation is
blocked. Furthermore, we hypothesized that tumors from both
untreated and PDTC treated animals would show similar levels of
NFkB activity. We reasoned that any tumors formed despite
PDTC treatment would suggest the occurance of other molecular
events occurred thereby allowing specific cells to bypass PDTC-
mediated inhibition and develop into tumors. Therefore, we
expected the effects of PDTC and NFkB inhibition in UVB
Hairless Inhibits NF-kappaB and UVB Tumorigenesis
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bearing skin compared to non-treated SKH-1 animals.
PDTC inhibition of NFkB blocks downstream target
genes in chronically UVB exposed Hairless mutant skin
We began by assessing NFkB activation by Western blot
analysis of nuclear extracts; we found decreased nuclear localiza-
Figure 4. Hairless mutant epidermis shows constitutive activation of the NFkB signaling pathway. A) Western Blot and ImageJ
densitometry analysis using anti-p65 antibody on isolated Hr
2/2 epidermal extracts after 1, 8 and 24 hrs post UVB (180 mJ/cm
2) irradiation. B)
Immunohistochemistry using p-IkBa antibody to determine the extent of NFkB signaling activity in the epidermis of WT (Hr
+/+) and Hr
2/2 animals
before and after a single, acute UVB (180 mJ/cm
2) irradiation. IkBa is increased constitutively and after irradiation throughout the epidermal layer. C)
Immunohistochemistry using p-IkBa antibody to determine the extent of NFkB signaling activity in the epidermis of WT (Hr
+/+) and Hr
2/2 animals at
the indicated time points during chronic UVB irradiation (180 mJ/cm
2 UVB three times a week for a total of 50 weeks). IkBa is increased constitutively
and after irradiation throughout the epidermal layer.
doi:10.1371/journal.pone.0039691.g004
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epidermis and tumors but no change in p52 (Figure 5C). This
indicated that as expected, PDTC specifically blocked nuclear
translocation of the p65/p50 heterodimer and the canonical
NFkB pathway. We also found that PDTC treated epidermis
exhibited decreased NFkB activation as measured by direct
binding of NFkB to consensus binding sites, electrophoretic
mobility shift assay (EMSA)(Figure S3B). Total and phosphory-
Figure 5. Administration of the NFkB inhibitor PDTC abrogates UVB-induced skin carcinogenesis in SKH-1 mice. SKH-1 mice (n=30
per treatment) were chronically irradiated with UVB (180 mJ/cm
2, twice a week for 35 weeks) and either given PDTC (0.5%) or no treatment in
drinking water (ad libitum). Non-irradiated SKH-1 mice (n=12) were used as controls. A) PDTC treatment decreased the average number of tumors
per mouse. B) PDTC treatment decreased the average tumor volume per mouse. C) Western blot analysis for the p50, p52, and p65 subunits of NFkB
were performed on nuclear extracts prepared from non-irradiated epidermal samples and chronically irradiated epidermal and tumor samples from
mice treated with PDTC or untreated. While PDTC treatment prevented the upregulation of p50 in both skin and tumor samples, it had no effect on
the p52 expression in either sample. PDTC treatment specifically abrogated upregulation of p65 in non-tumor bearing epidermis. D) RT-PCR for the
NFkB transcriptional targets TRAIL, IL-1b, TNF-a and Mn SOD was performed on non-irradiated epidermal samples and chronically irradiated
epidermis and tumor samples from mice treated with PDTC or untreated. PDTC prevented upregulation of the NFkB targets in irradiated skin samples
but not in tumor samples. E) Western blot analysis for cyclin D1, cyclin E, and PCNA (which are involved in cell cycle regulation) was performed on
non-irradiated epidermal samples and chronically irradiated epidermis and tumor samples from either untreated mice or mice treated with PDTC.
PDTC treatment abrogates the overexpression of these proteins in non-tumor bearing skin samples. F) Western blot analysis of caspase-3 (pro-
apoptosis), Bcl-2 (anti-apoptosis), and COX-2 (inflammation) was performed on non-irradiated epidermal samples and chronically irradiated epidermis
and tumor samples from mice treated with PDTC or untreated. PDTC inhibited Bcl-2 and COX-2 in both epidermis and tumor samples while it did not
affect caspase-3.
doi:10.1371/journal.pone.0039691.g005
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tumor bearing epidermis and tumors; it was found that PDTC
treatment specifically abrogated increases in phophorylated IkBa
in non-tumor bearing skin suggesting a functional blockade of the
NFkB signaling pathway (Figure S3C). Taken together, the data
indicates an overall reduction in NFkB signaling activity in the
non-tumor bearing skin of SKH-1 animals subjected to chronic
UVB exposure and treated with PDTC.
In order to assess the downstream consequences of NFkB
regulation by PDTC in SKH-1 animals, we analyzed the mRNA
expression of various NFkB target genes in epidermal extracts and
tumors using semi-quantitative PCR. As shown in Figure 5D, we
found that PDTC treatment significantly reduced the expression of
TRAIL [35], IL-1b [36], TNFa [37], and MnSOD [38] in the
non-tumor bearing epidermis with a less appreciable decrease in
tumors. This data confirms that NFkB activation is crucial for
tumor development in chronically UVB irradiated SKH-1 skin,
and that PDTC efficiently blocked NFkB activation in non-tumor
bearing skin, thus attenuating the susceptibility of SKH-1 animals
to tumor development.
To further investigate the PDTC-dependent repression of
tumor susceptibility in chronically irradiated Hairless mutant mice,
we studied its effects on the expression of genes that regulate cell
cycle progression, proliferation, and apoptosis. As shown in
Figure 5E, PDTC treatment inhibited the expression of the key
cell cycle regulators cyclin D1 [39], cyclin E1 [40], and PCNA
[41] in both tumors and in non-tumor bearing epidermis. When
combined with the increased Ki67 staining seen in Figure 3B,
increased expression of these proteins in irradiated SKH-1 skin
and tumors is yet another indication of a hyperproliferative state
that can be abrogated by blockade of the NFkB pathway.
We then examined the expression of two proteins involved in
apoptotic response pathways, the pro-apoptotic caspase 3 and the
anti-apoptotic Bcl-2. Caspase 3 has not been implicated in the
NFkB pathway so as expected, we saw no significant change in
expression with PDTC treatment (Figure 5F). Bcl-2, however, is a
known NFkB target gene and its expression is decreased with
PDTC treatment in both non-tumor bearing epidermis and
tumors (Figure 5F) [42]. This is consistent with the TUNEL and
Ki67 results in Figures 3B and 3C that show increased
proliferation and decreased apoptosis, which together with the
data presented here, illustrates that repression of NFkB restores
the normal apoptotic response in the irradiated Hr mutant
epidermis.
To further understand the mechanism behind increased tumor
promotion in the context of NFkB activation, we assessed the
expression of the pro-inflammatory protein COX-2. COX-2 is
known to be downstream of NFkB and is strongly implicated in
squamous cell carcinoma progression [43,44,45]. In agreement
with the expression pattern of the other pro-inflammatory NFkB
target genes TNFa and IL-1b, we found that COX-2 levels were
dramatically decreased with PDTC treatment in non-tumor
bearing skin but not in tumors. Therefore, we theorize that in
the Hr mutant epidermis, increased COX-2 levels in conjunction
with TNFa and IL-1b create an pro-inflammatory environment
that promotes tumor growth [46].
Discussion
Hairless mice, particularly the SKH-1 line, have long been a
favorite animal model used for skin carcinogenesis studies because
of their convenience, however, researchers have not generally
taken into consideration the underlying mechanism for their lack
of hair and whether this may be linked to their tumor
susceptibility. To address this issue, we show for the first time
that Hr
2/2 and SKH-1 mouse lines are allelic mutants of one
another that have significantly lower amounts of Hr, a crucial early
UVB response gene, and are thus predisposed to UVB induced
carcinogenesis. The results detailed above indicate that Hr plays a
crucial role in cell cycle kinetics by functioning as an inhibitor of
the NFkB pathway in the epidermis; therefore, loss of Hr results in
altered cell cycling, increased proliferation and subsequent
tumorigenesis.
We found that both Hr
2/2 and SKH-1 animals exhibit similar
decreases of Hr expression throughout the skin that amounts to
approximately 30% of that found in WT animals; this allowed
them to be used interchangeably in our experiments. We further
determined that Hr is significantly upregulated in the WT
epidermis 8 hours after a single, acute dose of UVB. Furthermore,
when Hr
2/2 mice were used in chronic UVB carcinogenesis
studies they developed papillomas by week 30, and these
papillomas progressed into aggressive SCCs by the end of the
protocol 20 weeks later. In contrast, WT mice with normal Hr
expression failed to show even microscopic signs of tumorigenesis
by week 50.
Together, these findings led us to postulate that Hr is an
essential component of the epidermal response to UVB insult and
perturbation of Hr levels causes a genetic predisposition to
tumorigenesis due to a dysregulated UVB response in the Hr
mutant epidermis. Under normal conditions, a tightly regulated
signaling cascade is triggered by UVB irradiation leading to the
apoptosis of severely damaged cells and proliferation of undam-
aged and/or repaired cells (reviewed in [47]). Therefore, we
examined the epidermis of Hr
2/2 animals and found that at
homeostasis Hr loss results in a significantly thicker epidermis that
is sustained after UVB exposure. We then investigated the
contribution of both proliferation and apoptosis to this thicker
epidermis and found both increased proliferation at all time points
and decreased apoptosis in response to UVB irradiation. This
indicated that the thicker epidermis found in Hr mutant mice was
the result of uncontrolled proliferation and decreased apoptosis,
factors which when combined together contribute to the increased
tumorigenesis seen during the chronic UVB exposure protocol. It
should be noted that the thicker epidermis in and of itself might
contribute to the decreased apoptosis due to possible UVB
shielding.
One of the key mechanistic links between proliferation and
apoptosis is the NFkB signaling pathway and we have previously
established a regulatory loop between Hr and NFkB in vitro
[29,46]. Thus we investigated a possible mechanistic connection
between NFkB and Hr in vivo. While there are many NFkB hetero-
and homo-dimers that can activate NFkB-mediated transcription
and regulate cell proliferation, we began by focusing on the
canonical p65/p50 hetero-dimer complex since it is known to be
an important UVB response factor in both mouse and human skin
[24]. We found that at homeostasis, Hairless mutant epidermis
exhibits constitutive activation of the NFkB pathway as indicated
by increased expression of both the p65 subunit and p-IkBa.
Unlike in the WT epidermis, p-IkBa activation in the Hr
2/2 skin
is not confined to the superbasal layer; instead p-IkBa is expressed
throughout the epidermis both basely and in response to UVB
thererby indicating aberrant upregulation of NFkBi nHr
2/2 skin.
We postulate that Hr regulates tumor promotion via regulation
of NFkB activation and thereby modulates proliferation and
apoptosis following UVB irradiation. Therefore, when Hr
expression is decreased, there is an increased likelihood of the
survival and proliferation of UVB damaged basal keratinocytes
and subsequent tumorigenesis. As we also show here, blockade of
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decreases both tumor burden and tumor volume in the Hairless
mutant mouse line SKH-1.
In the non-tumor bearing skin irradiated SKH-1 mice, PDTC
treatment specifically decreased NFkB activity in the Hairless
mutant epidermis as reflected by attenuated expression of the
NFkB subunits p50 and p65, decreased NFkB binding to target
sequences, and decreased expression of p-IkBa. Additionally, the
non-tumor bearing skin of PDTC treated mice also exhibited
decreases in the expression of downstream NFkB targets such as
TRAIL, IL-1b, TNFa, and MnSOD as well as the inhibition of
cell cycling proteins such as cyclin D1, cyclin E, PCNA, and BCL-
2 thereby indicating a return to normal proliferation. We also
show that in non-tumor bearing skin, Hr influences inflammation
via COX-2 expression which decreases with PDTC treatment.
The combination of decreased TNFa, IL-1b, and COX-2 found
in the PDTC treated epidermis provides compelling evidence that
Hr is capable of modulating epithelial inflammation via regulation
of the NFkB pathway and thereby further contributes to tumor
promotion. Therefore, the data provides evidence that the
decreases in Hr expression result in gross epithelial dysregulation
that can be ameliorated by inhibition of the NFkB pathway.
We hypothesize that since NFkB is the nexus of proliferative
and inflammatory signals [46], the lack of Hr allows the
proliferation of UVB damaged cells and eventual tumor develop-
ment. Previous work in our laboratory has shown that after UVB
insult, cells lacking Hr have decreased amounts of cells in the G2/
M phase [29] which is a key cell cycle checkpoint for DNA
damage [48,49]. Attenuation of the G2/M checkpoint after UVB
insult increases genomic instability which when combined with
increased proliferation and inflammation found in the Hairless
mutant epidermis creates an ideal cellular environment for tumor
development. Thus, loss of Hr and subsequent overactivation of
NFkB provide all the components necessary for increased
tumorigenesis.
While it is possible that Hr-mediated repression of the NFkB
pathway could occur at multiple junctures due to the inherent
complexities of the NFkB pathway, the evidence presented here
suggests the involvement of Hr in two possible regulatory
mechanisms. One is through the control of the kinase cascade
leading to IkBa phosphorylation and subsequent degradation.
This then allows the canonical NFkB heterodimer to translocate to
the nucleus, bind to target DNA sequences, and modulate
downstream gene transcription. This possibility is seen in the
increased IkBa staining seen in Hr
2/2 epidermis both prior to and
after irradiation. The other possible regulatory mechanism is
through direct transcriptional regulation of the p65 subunit.
Evidence for this regulation is seen in the increased expression of
p65 in epidermal extracts from unirradiated and irradiated Hr
2/2
mice. Since IkBa is also downstream of NFkB activation, direct
transcriptional regulation of the NFkB subunits would also result
in the increased IkBa phosphorylation seen in the Hr mutant
epidermis. Therefore either hypothesis fits the data presented here
and further work will be necessary to clarify the method of Hr
regulation of NFkB.
While non-tumor bearing skin showed significant changes with
PDTC, there were less obvious effects in the tumor samples. We
postulate that specific keratinocyte populations escaped PDTC-
mediated inhibition of NFkB and developed into tumors despite
PDTC treatment. We further postulate that this escape may be
due to other molecular events such as DNA damage in other genes
downstream of PDTC inhibition of the NFkB pathway. Therefore,
the effects of PDTC are more prominent in the non-tumor bearing
skin and a small number of tumors develop despite PDTC
treatment.
Altogether, we provide here multiple lines of evidence that Hr
plays an essential role in the regulation of NFkB signaling in the
epidermis and thereby effects keratinocyte apoptosis and prolifer-
ation. Hr mediated NFkB regulation occurs during epidermal
homeostasis but it is particularly important during the keratinocyte
response to UVB irradiation where it is essential to the proper
apoptosis of damaged keratinocytes. Thus, we postulate that Hr
plays a crucial regulatory role in SCC development via inhibition
of NFkB pathway after UVB irradiation. We conclude that Hr
mutant mouse strains, including SKH-1, exhibit qualities associ-
ated with increased proliferation and cellular dysregulation,
providing a molecular mechanism for their inherent tumor
susceptibility.
Materials and Methods
Animals
SKH-1 mice were purchased from Charles River Laboratories
(Kingston, NY). HRS/J (Hr
2/2) were purchased from Jackson
Laboratory (Bar Harbor, ME). This study was carried out in strict
accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of
Health. The protocol was approved by the Institutional Animal
Care and Use Committee of Columbia University (IACUC
Protocol Number: AC-AAAA5875).
RNA and Protein Extraction
Dorsal skin was harvested from mutant and WT animals and
divided into two parts; one portion was kept intact for histological
analysis and RNA extraction (see below) and the other was used
for epidermal isolation and subsequent RNA and protein
extraction. Briefly, dorsal whole skin was scraped to remove
excess subcutaneous fat and divided into small strips and
incubated in 0.25% trypsin with EDTA (Invitrogen, Grand
Island, NY) for 2 hrs at 37uC. The epidermis was mechanically
separated from the dermis by scraping and incubated in SMEM
with 10% FBS, 1% PS (Invitrogen) at room temperature with
shaking for 30 min to separate the keractinoyctes. Keratinocyte
clumps were then filtered out using a 70 mM cell strainer (BD
Biosciences, San Diego, CA) and the remaining single cell filtrate
was pelleted by centrifugation. The cells were then resuspended in
either RLT Buffer for RNA Extraction (Qiagen, Valencia, CA) or
the Flag-Lysis Buffer (50 mM Tris-HCl pH 7.8, 137 mM NaCl,
10 mM NaF, 1 mM EDTA, 1% Triton X-100, 0.2% Sarkosyl,
1 mM DTT, 10 % glycerol and fresh proteinase inhibitors) for
protein extraction.
A portion of the whole skin was also homogenized in RLT
Buffer and RNA was isolated from either the epidermis or the
whole skin using an RNeasy Mini Kit (Qiagen) followed by DNase
treatment. 2 mg of total RNA was used for the cDNA synthesis
using Superscript III (Invitrogen) and a 2:1 ratio of random
hexamers: oligo (dT) primers according to manufacturer’s
instructions.
Protein was extracted from either epidermal extracts or whole
tumors homogenized in Flag-Lysis buffer. Proteins were quantified
using RD DC protein assay protocol as instructed by the
manufacturer (BioRad, Hercules, CA). Relative band intensity
was measured using ImageJ software.
Quantitative RT-PCR
Real time PCR was performed on a ABI 7300 (Applied
Biosystems, Carlsbad, CA) using the Relative Quantification Assay
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guidelines.
All are written 59 to 39:
mHr ex 6 FTTCCACATTGCTGCAGTCAT
mHr ex 6/7 RGTTCTCAGG AACAGCA
mHr ex15 FCTGGTATCGAGCACAGAAAG
mHr ex 16 FCTTTCTCCAGATGGTGTGC
mB2M FACTGACCGGCCTGTATGCTA
mB2M RTAGAGATGTCAGATATGTCCTTCA
mTNF-a FTGCCTATGTCTCAGCCTCTT
mTNF-a RGGAAGACTCCTCCCAGGTAT
mIL-1b FATAACCTGCTGGTGTGTGAC
mIL-1b RTGAGGTGCTGATGTACCAGTT
mMnSOD FGACCTGCCTTACGACTATGG
mMnSOD R GACCTTGCTCCTTATTGAAGC
mTRAIL FTCACCAACGAGATGAAGCAGC
mTRAIL RCTCACCTTGTCCTTTGAGACC
All reactions were performed using ABI Power Sybr Master
Mix, 200nM primers and 200ng cDNA. The following protocol
was used: step 1 250uC 2 min, step 2 295uC 10 min, step 3
295uC 15 sec, step 4 260uC 1 min, repeat step 2–4 for 40 cycles.
All samples were run on a 1.5% agarose gel to confirm amplicon
size. The data output was imported into the GraphPad Prism 4
software (GraphPad Software, Inc., La Jolla, CA), plotted, and the
error calculated as standard error of the mean (SEM). Statistical
analysis was performed between time points and samples as
indicated using Student’s T-test.
UV irradiation protocol
For all protocols, irradiation was performed using eight
FS72T12-UVB-HO lamps (Daavlin, Bryan, OH) and all animals
were irradiated at 180 mJ/cm
2 UVB which has been established
as approximately equivalent to 2 MEDs [30,31]; UVC was
eliminated by a Kodacel filter (TA401/407) (Kodak, Rochester,
NY). The UVB dose was measured with a UVB Spectra
305 Dosimeter (Daavlin) and calibrated with a secondary
radiometer (IL1700) (International Light, Peabody, MA).
Chronic UVB protocol. Female 9–11 week old HRS/J and
shaved WT counterparts (n=10 for each) were irradiated three
times a week for a total of 50 weeks. Tumors were counted when
they reached 2 mm in diameter on a weekly basis. After 25 and
30 weeks of irradiation mice were randomly selected for
euthanization. At 42 weeks of irradiation mice were chosen for
sacrifice based on their tumor size; any animal with an average
tumor diameter greater than 7.5 mm was euthanized. After
50 weeks of irradiation the remaining mice were sacrificed. At all
timepoints skin and tumor samples were embedded in both
paraffin and frozen blocks.
Chronic UVB protocol with PDTC treatment. 60 9–11
week old SKH-1 mice were split into two groups of 30 animals
each, one group received no treatment and the other group
received 0.5% PDTC in their drinking water. PDTC treatment
began 2 weeks prior to first irradiation and continued throughout
irradiation protocol. Both groups were irradiated twice a week
with for a total of 35 weeks. 12 SKH-1 mice served as non-
irradiated, untreated, age matched controls. When tumor diam-
eter reached 2 mm, the tumor number and size were recorded
biweekly. All animals were sacrificed 24 hrs after last UVB
exposure and dorsal skin and tumors were collected for Western
blotting, EMSA and RT-PCR analysis. Three samples for each
group was used per assay and each assay was repeated for a total of
three times.
Acute UVB protocol. Female 9–11 week old HRS/J and
shaved WT counterparts were irradiated once. Three animals of
each group per post irradiation timepoint were used for
4 replicates (n=12).
Immunohistochemistry
Skin samples for frozen blocks were prepared and embedded as
previously described [50]. Sections were done at 4 mm, parallel to
the paravertebral line, fixed in buffered 4% paraformaldehyde
with 1% Triton-X and processed for H&E, TUNEL (Apo-Tag kit)
(Chemicon, Billerica, MA) and Ki-67 (AbCam, Cambridge, MA)
staining. Epidermal morphometry was measured on H&E stained
sections using AdobePhotoshop. Approximately 20 measurements
(from basement membrane to stratum corneum) were made per
2.5 mm section at 10X objective on a HRC Axiocam fitted onto
an Axioplan2 fluorescent microscope (Carl Zeiss, Thornwood,
NY). TUNEL and Ki67 positive cells were counted per 2.5 mm
section of skin at 20X. For Ki67 analysis the total number of basal
keratinocytes were also counted in the same field of view. Data was
plotted and analyzed using GraphPad Prism 4 software. Error was
calculated as standard error of the mean (SEM).
For phospho-IkBa staining, tissue was fixed in 10% formalin,
embedded in paraffin blocks and sectioned at 4 mm parallel to
paravetebral line following standard procedures. Sections were
treated with Antigen Unmasking Solution (Vector Labs, Burlin-
game, CA) then probed with phospho-IkBa (ser32/36) (AbCam)
followed by avidin-biotintylated HRP complex (ABC Elite system,
Vector Labs). The antibody was detected with DAB and images
were taken using a HRC Axiocam fitted onto an Axioplan2
fluorescent microscope.
Western Blots
Protein extracts were prepared as described above, while
nuclear extracts were prepared using NE-PER Nuclear and
Cytoplasmic Extractions kit (Pierce, Rockford, IL). All samples
were used for Western blotting analysis using standard protocols
and the following primary antibodies: p65 (AbCam), p50 (Santa
Cruz, Santa Cruz, CA), and p52 (Santa Cruz). Western blotting
was done using standard protocols and the following primary
antibodies: IkBa (Santa Cruz) IkBa (ser32/36) (AbCam), PCNA
(Santa Cruz), Bcl-2 (Enzo Life Sciences, Farmingdale, NY), active
caspase 3 (AbCam), Cyclin D1 (Cell Signaling Technology,
Boston, MA), Cyclin E (Santa Cruz), COX-2 (Santa Cruz), and
b-actin (Sigma-Aldrich, St Louis, MO). Appropriate horseradish-
peroxidase conjugated secondary antibodies (Jackson ImmunoR-
esearch, West Grove, PA) were used at 1:1000 and visualized using
SuperSignal West Dura Chemiluminescent Substrate (Pierce,
Rockford, IL). Relative band intensity was measured using ImageJ
(NIH, Bathesda, MD).
EMSA
3.5 pmol of NFkB consensus oligonucleotide (59- AGTT-
GAGGGGACTTTCCCAGGC-39) (Promega, San Louis Obispo,
CA) was 5’ labeled with [c-32P] ATP using T4 polynucleotide
kinase (Promega). Nuclear protein extracts were incubated in Gel
Shift Binding Buffer (Promega) containing 20% glycerol (v/v),
5mM MgCl2, 2.5mM EDTA, 2.5mM DTT, 250mM NaCl and
50mM Tris-HCl (pH 7.5) and labeled oligonucleotide. In compe-
tition experiments, a 100-fold molar excess of unlabeled probe was
added before the labeled probe. Reaction products were separated
on 4% a polyacrylamide gel, after which the gel was dried and
exposed to X-ray film overnight at 270uC.
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Figure S1 SKH-1 and Hr
2/2 mice contain the same
proviral insertion. A) Schematic layout of primer locations and
insertion site. B) Using PCR primers designed to intron 5F and
intron 6R1 (lane1) yields a product in all genotypes, while primers
designed to intron6F, mid intron6R2 (lane2), and exon6/intron6F,
intron6R3 (lane3) amplifies only in the WT samples indicating an
insertion is present causing the PCR to fail. C) Using Hairless
specific Hairless primer (ex6/intron6F) and viral specific reverse
primers (lane3), products were observed only in the mutants
indicating SKH-1 and Hr
2/2 have the same viral insertion. D)
DNA sequencing was performed to confirm the insertion as the
same as that found in Hr
2/2. Black arrow indicates the insertion
site junctions.
(TIF)
Figure S2 Hr
2/2 animals are unaffected by chronic
UVB irradiation until 30 weeks. A) At 22 weeks of chronic
UVB irradiation, neither WT nor Hr
2/2 animals show any signs
of tumorigenesis. B) By 30 weeks of chronic UVB irradiation, Hr
2/
2 animals begin to develop small papillomas.
(TIF)
Figure S3 PDTC treatment prevents tumorigenesis and
activation of NFkB in SKH-1 animals. A) After 35 weeks of
chronic UVB irradiation, SKH-1 animals given only tap water
develop tumors with the gross morphology of aggressive SSCs.
PDTC treated SKH-1 animals at the same time point develop
significantly less tumors that appear to be less aggressive. B) EMSA
using samples derived from unirradiated epidermis, non-tumor
bearing epidermis from untreated and PDTC-treated animals, and
tumors from untreated and PDTC-treated animals. PDTC
treatment significantly decreases NFkB binding to target sequenc-
es (indicated by black arrow). C) Western blot of IkBa and p-IkBa
from unirradiated epidermis, non-tumor bearing epidermis from
untreated and PDTC-treated animals, and tumors from untreated
and PDTC-treated animals. PDTC treatment decreased p-IkBa
expression in the non-tumor bearing skin of irradiated animals.
(TIF)
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